Surgical Treatment Outcomes of Abdominal Aortic Endograft Infection: A Dual-Center Retrospective Study
Annals of Vascular Surgery · 2026
DOI: 10.1016/j.avsg.2026.06.018 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Vascular Surgery, 2026. Verfasst von Xuebin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis, Endovascular Aneurysm Repair, Aortic Aneurysm, Abdominal, Prosthesis-Related Infections. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Beijing Friendship Hospital, Capital Medical University, Capital Medical University.
Abstract (Originalsprache)
BACKGROUND: Abdominal aortic endograft infection (AAEI) is a rare but life-threatening complication following endovascular aneurysm repair. This study aimed to report surgical outcomes of AAEI from 2 specialized Chinese vascular centers and analyze prognostic risk factors. METHODS: A dual-center retrospective cohort study enrolled 41 patients who underwent complete infected graft excision and revascularization for AAEI between February 2018 and September 2025. Clinical data were collected and analyzed via Kaplan-Meier survival analysis and univariate COX regression. RESULTS: This cohort included 40 males and 1 female (mean age: 64.22 ± 9.12 years). Complete removal of the infected graft was performed in all cases, with revascularization achieved via extra-anatomical bypass (EAB, n = 39) or in situ reconstruction (n = 2). Median follow-up time was 12 months. All-cause mortality was 29.3%, nonfatal complication rate was 39.0% and reintervention rate was 17.1% (7/41). Elevated white blood cell (WBC) (P = 0.01, hazard ratio [HR] = 3.90) and enteric fistula (P = 0.04, HR = 3.21) worsened survival; advanced age showed a trend toward significance (P = 0.09). C-reactive protein level and renal artery stent coverage had no significant prognostic impact (P > 0.05). CONCLUSION: EAB is a feasible and practical option for high-risk AAEI patients, particularly at centers lacking biological grafts. Enteric fistula, elevated preoperative WBC, and advanced age predict poor survival. Large prospective multicenter trials are needed to refine individualized treatments for AAEI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of Vascular Surgery, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Institute of Geriatric Medicine, Beijing, China.
- Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Electronic address: Fenghai543@126.com.
Förderung
- Beijing Natural Science Foundation
- Beijing Friendship Hospital, Capital Medical University
- Capital Medical University
Zitieren
APA
Wang, X., Diao, Y., Qi, B., Wu, Z., Lian, L., Zhang, Z., Jin, S., Chen, X., Li, Y., & Feng, H. (2026). Surgical Treatment Outcomes of Abdominal Aortic Endograft Infection: A Dual-Center Retrospective Study. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2026.06.018
Vancouver
Wang X, Diao Y, Qi B, Wu Z, Lian L, Zhang Z, et al. Surgical Treatment Outcomes of Abdominal Aortic Endograft Infection: A Dual-Center Retrospective Study. Annals of Vascular Surgery. 2026. doi:10.1016/j.avsg.2026.06.018
BibTeX
@article{Wang2026,
author = {Wang, Xuebin and Diao, Yongpeng and Qi, Bingcai and Wu, Zhiyuan and Lian, Lishan and Zhang, Zhe and Jin, Shanshan and Chen, Xueming and Li, Yongjun and Feng, Hai},
title = {Surgical Treatment Outcomes of Abdominal Aortic Endograft Infection: A Dual-Center Retrospective Study},
journal = {Annals of Vascular Surgery},
year = {2026},
doi = {10.1016/j.avsg.2026.06.018}
}
EUVIMED